Trademark Overview
On Tuesday, October 8, 2024, a trademark application was filed for GENELEAP with the United States Patent and Trademark Office. The USPTO has given the GENELEAP trademark a serial number of 98790150. The federal status of this trademark filing is NEW APPLICATION - ASSIGNED TO EXAMINER as of Friday, April 11, 2025. This trademark is owned by GeneLeap, Inc.. The GENELEAP trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical information services, namely, preparation and generation of reports identifying drug ang gene interactions, calculating drug dosages and making treatment recommendations through proprietary software applications; Medical testing services, namely, providing medical tests that measure, analyze and interpret genes of patients to personalize medication selection and treatment choices, identify potentially harmful drug interactions and calculate drug dosage adjustments for patients; Predictive medical analysis services relating to the selection of treatments for psychiatric conditions
Providing on-line non-downloadable software for analyzing drug-receptors, identifying drug ang gene interactions, calculating drug dosages and making treatment recommendations; Providing on-line non-downloadable software that uses artificial intelligence for identifying and analyzing gene and drug interactions, calculating drug dosages, and making treatment recommendations; Providing on-line non-downloadable software that uses artificial intelligence for optimizing and individualizing drug therapies for major depressive disorder and psychiatric disorders
